<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/6C747631-6855-48CC-BF64-0316AABB5DF8"><gtr:id>6C747631-6855-48CC-BF64-0316AABB5DF8</gtr:id><gtr:name>University of Malta</gtr:name><gtr:address><gtr:line1>Administration Bldg</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9C802A04-ED90-499D-BA25-98D28CC2BE14"><gtr:id>9C802A04-ED90-499D-BA25-98D28CC2BE14</gtr:id><gtr:name>Prince Henry's Inst for Medical Research</gtr:name><gtr:address><gtr:line1>PO Box 5152</gtr:line1><gtr:postCode>3168</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D2A7E780-D923-4D61-B58E-3E467D303CA0"><gtr:id>D2A7E780-D923-4D61-B58E-3E467D303CA0</gtr:id><gtr:name>University of Adelaide</gtr:name><gtr:address><gtr:line1>Main Building</gtr:line1><gtr:line4>Adelaide</gtr:line4><gtr:line5>SA 5005</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:department>Basic Medical Sciences</gtr:department><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/6C747631-6855-48CC-BF64-0316AABB5DF8"><gtr:id>6C747631-6855-48CC-BF64-0316AABB5DF8</gtr:id><gtr:name>University of Malta</gtr:name><gtr:address><gtr:line1>Administration Bldg</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9C802A04-ED90-499D-BA25-98D28CC2BE14"><gtr:id>9C802A04-ED90-499D-BA25-98D28CC2BE14</gtr:id><gtr:name>Prince Henry's Inst for Medical Research</gtr:name><gtr:address><gtr:line1>PO Box 5152</gtr:line1><gtr:postCode>3168</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D2A7E780-D923-4D61-B58E-3E467D303CA0"><gtr:id>D2A7E780-D923-4D61-B58E-3E467D303CA0</gtr:id><gtr:name>University of Adelaide</gtr:name><gtr:address><gtr:line1>Main Building</gtr:line1><gtr:line4>Adelaide</gtr:line4><gtr:line5>SA 5005</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/F602F714-F63C-4F28-A05F-51C46781DE1B"><gtr:id>F602F714-F63C-4F28-A05F-51C46781DE1B</gtr:id><gtr:firstName>Malcolm</gtr:firstName><gtr:surname>Parker</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/249117A7-50EF-4EC2-94B4-2D4A2494A73E"><gtr:id>249117A7-50EF-4EC2-94B4-2D4A2494A73E</gtr:id><gtr:firstName>Helen</gtr:firstName><gtr:surname>Mason</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0700916"><gtr:id>2F12C83C-0C42-49A7-86C7-1F57A683B46E</gtr:id><gtr:title>Ovarian anti-Mullerian hormone: what does it do in the normal ovary and why is it so high in polycystic ovary syndrome?</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0700916</gtr:grantReference><gtr:abstractText>In the womb, boy babies develop part of their reproductive system because of the actions of a hormone called anti-Mullerian hormone (AMH). Interestingly, this hormone has now been shown to play a part in adult women in that it is involved in the working of the ovary. In the ovary each month an egg is grown and released. We have found that only those eggs which have got rid of AMH manage to grow. This is important because we have also found that the levels of this hormone are very high in a common condition which causes infertility. We now need to find out why the levels are high in these women and what exactly AMH does in the ovary. We hope that this will allow us to help these women to have better fertility in the future.</gtr:abstractText><gtr:technicalSummary>The male fetal sexual differentiative factor anti-Mullerian hormone is a potentially important signalling molecule in the adult ovary. Although much of this information was derived from knock-out mice, AMH is increasingly being heralded as a clinical marker of ?fertility?. Very little is known about its production or action in human ovary. We have discovered that, although AMH is high in human follicles of 2-6 mm, it is absent from follicles progressing beyond selection. Preliminary results indicate that this is because it inhibits FSH-stimulated aromatase, an inhibition which would limit continued folliculogenesis. We now wish to elucidate the mechanism of this inhibition. This work will be carried out in human granulosa cells and we will focus on the function of specific SMADs using siRNAs, dominant negatives and overexpression. We will then determine which aromatase promoter II-associated transcription factors are altered by AMH treatment and gel shift assay. In parallel with this candidate approach we will screen for other differentially expressed genes in granulosa and theca cells from normal ovaries exposed to AMH using microarray. 
Our observation that AMH levels in cells from polycystic ovaries are 75 times higher than those from normal has important implications for fertility in these women. Our second aim therefore is to elucidate the molecular basis for the upregulated AMH expression. We will investigate alterations in transcriptional regulation of the gene by investigating promoter activity in granulosa cells from PCO and normal ovaries. In this way we will distinguish between the failure to repress versus the acquisition of promiscuous activation in PCOS. It is also conceivable that the upregulation reflects alterations in AMH protein turnover which we will investigate by measuring the half-life of tagged versions of AMH in the two types of granulosa cells. This will also permit us to understand the normal mechanism of the control of AMH production in the developing follicle.
If AMH is to be used as an important clinical marker then we need to understand its production and actions. Determining how and why AMH levels are tightly controlled in the follicle at the critical time of selection will add fundamental knowledge to this key process. Anovulation is an important consequence of PCOS for many women and yet the cause remains unknown and treatments are far from perfect. As AMH is only made by granulosa cells, elucidating its role in inhibition of follicle progression may make it an ideal target for treatment.</gtr:technicalSummary><gtr:fund><gtr:end>2011-08-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>305730</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Adelaide</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>Discipline of Obstetrics and Gynaecology</gtr:department><gtr:description>Ovarian fibrillin-3</gtr:description><gtr:id>08649FA2-69EF-4946-BF6A-034CA18262FA</gtr:id><gtr:impact>2 publications</gtr:impact><gtr:piContribution>discussion of protocol and provision of human ovarian tissue samples for investigation</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Prince Henry's Institute (PHI)</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>control of aromatase</gtr:description><gtr:id>630C4924-EC29-4025-8B0F-F01D818D98EA</gtr:id><gtr:impact>publication
conference presentations</gtr:impact><gtr:partnerContribution>Following a one-month visit to Melbourne the funded postdoc developed a new technique which was used in our subsequent publications. We have had continual discussions regarding ovarian aromatase and contunue to do so.</gtr:partnerContribution><gtr:piContribution>we have invesigated the effect of metformin on aromatase in ovrian cells</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Malta</gtr:collaboratingOrganisation><gtr:country>Malta, Republic of</gtr:country><gtr:department>Department of Obstetrics and Gynaecology</gtr:department><gtr:description>ovarian tissue</gtr:description><gtr:id>559452BD-1421-4FB3-AD2C-5CEE589FD050</gtr:id><gtr:impact>publications
conference presentations</gtr:impact><gtr:partnerContribution>the team in Malta work hard to sourse suitable material for our studies from their surgical patients. they also make available laboratory facilities for conducting experiments in Malta</gtr:partnerContribution><gtr:piContribution>we carry out the research</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>patient charity meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>6FCF350C-4727-4B85-B306-78B4B53DB264</gtr:id><gtr:impact>102 patients attended a day on PCOS in which i spoke for 1 hr and then had 1hr questions

good patient feedback. 'the first time i have understood it', 'makes me feel better to know that research is being done'</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk to GPs</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>79C78CD3-367D-4BF6-B560-16EB58192904</gtr:id><gtr:impact>100+ GPs attended talk which generated many questions about AMH

Resulted in invitations elsewhere</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk to healthcare professionals London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>7A618E87-2A4A-42B1-8143-744CDBE717AD</gtr:id><gtr:impact>Research included in a talk on PCOS

Increased activity on the PCOS-uk website (but this was from the whole day)</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interviews for magazines and newspapers</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>8EDCA870-1CE9-4485-8C7A-DCCA124C0D6A</gtr:id><gtr:impact>regularly give interviews over phone to journalists regarding PCOS and always try to include research findings. Most want to know them anyway!

Causes a cascade..ie increases contacts from other journalists, especially freelance
resulted in a number of invitations to speak at healthcare professionals meetings
2 page spread in Times 
Interest from TV producer who is in talks to raise fundes for programme</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk to patients- London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9216E81D-8112-456D-8979-A9B3FC268309</gtr:id><gtr:impact>Included research findings in talk on PCOS to patient self-help group Verity.

Interviews for magazines. Full page on work in medical school journal
2009 talk attended by journalist from Times who subsequently produced 2 page spread mentioning the MRC and their funding of our work</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008,2009,2012,2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>600</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel Award</gtr:description><gtr:end>2010-07-02</gtr:end><gtr:fundingOrg>Endocrine Society (USA)</gtr:fundingOrg><gtr:id>3C38A52D-CA7C-4799-96B9-AB7342DF35AD</gtr:id><gtr:sector>Learned Society</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5058</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>St. George's, University of London Research priming funds</gtr:description><gtr:end>2010-10-02</gtr:end><gtr:fundingOrg>St George's University of London</gtr:fundingOrg><gtr:id>AA57C519-60FF-4A1B-B264-1341F39C156C</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>University of London Central research fund</gtr:description><gtr:end>2011-08-02</gtr:end><gtr:fundingOrg>St George's University of London</gtr:fundingOrg><gtr:id>B3D1A92A-5DB7-42EF-8B2B-97344E77F076</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Best Poster Prize</gtr:description><gtr:end>2011-03-02</gtr:end><gtr:fundingOrg>International Society of Gynecological Endocrinology (ISGE)</gtr:fundingOrg><gtr:id>127FAE01-BED4-42D7-BF55-DD3D239EA9BD</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>600</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel Award</gtr:description><gtr:end>2009-07-02</gtr:end><gtr:fundingOrg>Endocrine Society (USA)</gtr:fundingOrg><gtr:id>934A118D-57B6-4282-A815-491CCBFA39C5</gtr:id><gtr:sector>Learned Society</gtr:sector><gtr:start>2009-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>87000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Thomas Addison PhD studentship</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>St George's University of London</gtr:fundingOrg><gtr:id>A14F9BDC-C000-462A-AA4C-558E599895D2</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/56DF1F94-0C04-4428-9FBE-4D768CD69543"><gtr:id>56DF1F94-0C04-4428-9FBE-4D768CD69543</gtr:id><gtr:title>Metformin inhibits aromatase via an extracellular signal-regulated kinase-mediated pathway.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/31e0eba4be1776c6fce6bf7de7d64ffa"><gtr:id>31e0eba4be1776c6fce6bf7de7d64ffa</gtr:id><gtr:otherNames>Rice S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FB350A8E-FE9E-4FD8-BF3B-6EB7094B33C0"><gtr:id>FB350A8E-FE9E-4FD8-BF3B-6EB7094B33C0</gtr:id><gtr:title>Metformin Inhibits Follicle-Stimulating Hormone (FSH) Action in Human Granulosa Cells: Relevance to Polycystic Ovary Syndrome</gtr:title><gtr:parentPublicationTitle>JOURNAL OF CLINICAL ENDOCRINOLOGY &amp; METABOLISM</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cde6316b75cfda002f059feb70098c20"><gtr:id>cde6316b75cfda002f059feb70098c20</gtr:id><gtr:otherNames>Rice Suman</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/32CB751A-42BB-4AC6-80DF-9873DD92F6AF"><gtr:id>32CB751A-42BB-4AC6-80DF-9873DD92F6AF</gtr:id><gtr:title>Phosphorylation and activation of AMP-activated protein kinase (AMPK) by metformin in the human ovary requires insulin.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0aef05d13a7f4f6fd1e1f3b20c447775"><gtr:id>0aef05d13a7f4f6fd1e1f3b20c447775</gtr:id><gtr:otherNames>Pellatt LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A66DA51F-2170-4718-965F-1E102D03D9BD"><gtr:id>A66DA51F-2170-4718-965F-1E102D03D9BD</gtr:id><gtr:title>Polycystic ovary syndrome:current and emerging concepts</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/31ea7ae50108513ae096268cea38453a"><gtr:id>31ea7ae50108513ae096268cea38453a</gtr:id><gtr:otherNames>Mason HD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A95D8F35-E021-4031-BEFE-BD90BF5FB37B"><gtr:id>A95D8F35-E021-4031-BEFE-BD90BF5FB37B</gtr:id><gtr:title>Action of vitamin D in the ovary: Novel effect on aromatase</gtr:title><gtr:parentPublicationTitle>Endocrine Society USA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/31e0eba4be1776c6fce6bf7de7d64ffa"><gtr:id>31e0eba4be1776c6fce6bf7de7d64ffa</gtr:id><gtr:otherNames>Rice S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E837D96C-71FC-4833-8CF1-5EF6ED988D82"><gtr:id>E837D96C-71FC-4833-8CF1-5EF6ED988D82</gtr:id><gtr:title>Linkage of regulators of TGF-? activity in the fetal ovary to polycystic ovary syndrome.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5799d4a3201bdfd4dc8403e10451968e"><gtr:id>5799d4a3201bdfd4dc8403e10451968e</gtr:id><gtr:otherNames>Hatzirodos N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F1FD56FC-149E-4593-8FDA-85937275006A"><gtr:id>F1FD56FC-149E-4593-8FDA-85937275006A</gtr:id><gtr:title>Metformin inhibits follicle-stimulating hormone (FSH) action in human granulosa cells: relevance to polycystic ovary syndrome.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/31e0eba4be1776c6fce6bf7de7d64ffa"><gtr:id>31e0eba4be1776c6fce6bf7de7d64ffa</gtr:id><gtr:otherNames>Rice S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3325C8C1-0C8D-4769-A45A-C1CB26555E58"><gtr:id>3325C8C1-0C8D-4769-A45A-C1CB26555E58</gtr:id><gtr:title>Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries.</gtr:title><gtr:parentPublicationTitle>Molecular human reproduction</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6e950cb78b2a7ddcda8185beab758e76"><gtr:id>6e950cb78b2a7ddcda8185beab758e76</gtr:id><gtr:otherNames>Prodoehl MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1360-9947</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D7AD0FA3-0C77-481E-BC46-447378320B82"><gtr:id>D7AD0FA3-0C77-481E-BC46-447378320B82</gtr:id><gtr:title>Action of metformin on the insulin-signaling pathway and on glucose transport in human granulosa cells.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/31e0eba4be1776c6fce6bf7de7d64ffa"><gtr:id>31e0eba4be1776c6fce6bf7de7d64ffa</gtr:id><gtr:otherNames>Rice S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D701E04A-6367-487E-A663-33930D8F671F"><gtr:id>D701E04A-6367-487E-A663-33930D8F671F</gtr:id><gtr:title>Phenotypes of the ovarian follicular basal lamina predict developmental competence of oocytes.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/76804d0bfac3bb6fa5d72ba5ecaf1a5c"><gtr:id>76804d0bfac3bb6fa5d72ba5ecaf1a5c</gtr:id><gtr:otherNames>Irving-Rodgers HF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CCACF722-C45C-48C7-9321-659E9B4FF87E"><gtr:id>CCACF722-C45C-48C7-9321-659E9B4FF87E</gtr:id><gtr:title>Anti-M&amp;uuml;llerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells.</gtr:title><gtr:parentPublicationTitle>Fertility and sterility</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bcde2f4821803548567c4ef8337b2ecd"><gtr:id>bcde2f4821803548567c4ef8337b2ecd</gtr:id><gtr:otherNames>Pellatt L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0015-0282</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/38AB1AEA-433F-4C63-B037-6BA19C71CA7D"><gtr:id>38AB1AEA-433F-4C63-B037-6BA19C71CA7D</gtr:id><gtr:title>Anti-M&amp;uuml;llerian hormone and polycystic ovary syndrome: a mountain too high?</gtr:title><gtr:parentPublicationTitle>Reproduction (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bcde2f4821803548567c4ef8337b2ecd"><gtr:id>bcde2f4821803548567c4ef8337b2ecd</gtr:id><gtr:otherNames>Pellatt L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1470-1626</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7D00069C-AB5C-40B3-8170-4A4C70974DB8"><gtr:id>7D00069C-AB5C-40B3-8170-4A4C70974DB8</gtr:id><gtr:title>Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review.</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e2ead3dfa5b4fc2b3bb471c97d744e2d"><gtr:id>e2ead3dfa5b4fc2b3bb471c97d744e2d</gtr:id><gtr:otherNames>Mason H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B5980DCE-6666-4F0E-ADAA-55505BF4D182"><gtr:id>B5980DCE-6666-4F0E-ADAA-55505BF4D182</gtr:id><gtr:title>Anti-Mullerian hormone may contribute to anovulation via inhibition of human granulosa cell growth</gtr:title><gtr:parentPublicationTitle>Endocrine Society USA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/814c9fe3793ea4e5e022705811621a00"><gtr:id>814c9fe3793ea4e5e022705811621a00</gtr:id><gtr:otherNames>Dilaver N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4F1FE1C0-7890-4AC2-A906-49106F74AD48"><gtr:id>4F1FE1C0-7890-4AC2-A906-49106F74AD48</gtr:id><gtr:title>The physiology and clinical utility of anti-Mullerian hormone in women.</gtr:title><gtr:parentPublicationTitle>Human reproduction update</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/726563cc83b0e76b7b9f9e43b88be765"><gtr:id>726563cc83b0e76b7b9f9e43b88be765</gtr:id><gtr:otherNames>Dewailly D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1355-4786</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EC696536-FA0D-49B5-B119-601D1B1F4F46"><gtr:id>EC696536-FA0D-49B5-B119-601D1B1F4F46</gtr:id><gtr:title>Ovarian 11?-hydroxysteroid dehydrogenase (11?HSD) activity is suppressed in women with anovulatory polycystic ovary syndrome (PCOS): apparent role for ovarian androgens.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/836780b4a731e8e437a215293c70d257"><gtr:id>836780b4a731e8e437a215293c70d257</gtr:id><gtr:otherNames>Michael AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700916</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>FA7AA693-7EDD-4A7E-8CA3-6B5658FBF717</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Reproductive Health and Childbirth</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>